204 related articles for article (PubMed ID: 22388630)
41. Radiometal targeted tumor diagnosis and therapy with peptide hormones.
Zwanziger D; Beck-Sickinger AG
Curr Pharm Des; 2008; 14(24):2385-400. PubMed ID: 18781989
[TBL] [Abstract][Full Text] [Related]
42. Nuclear medicine imaging and therapy of neuroendocrine tumours.
Gotthardt M; Dijkgraaf I; Boerman OC; Oyen WJ
Cancer Imaging; 2006 Oct; 6(Spec No A):S178-84. PubMed ID: 17114073
[TBL] [Abstract][Full Text] [Related]
43. Radiolabeled carbohydrated somatostatin analogs: a review of the current status.
Wester HJ; Schottelius M; Poethko T; Bruus-Jensen K; Schwaiger M
Cancer Biother Radiopharm; 2004 Apr; 19(2):231-44. PubMed ID: 15186604
[TBL] [Abstract][Full Text] [Related]
44. [99mTc]Demobesin 1, a novel potent bombesin analogue for GRP receptor-targeted tumour imaging.
Nock B; Nikolopoulou A; Chiotellis E; Loudos G; Maintas D; Reubi JC; Maina T
Eur J Nucl Med Mol Imaging; 2003 Feb; 30(2):247-58. PubMed ID: 12552343
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and evaluation of a technetium-99m labeled cytotoxic bombesin peptide conjugate for targeting bombesin receptor-expressing tumors.
Okarvi SM; Al Jammaz I
Nucl Med Biol; 2010 Apr; 37(3):277-88. PubMed ID: 20346867
[TBL] [Abstract][Full Text] [Related]
46. Radiometallated peptides targeting guanylate cyclase C and the urokinase-type plasminogen activator receptor.
Praharaj S; Overbey D; Giblin MF
Future Oncol; 2010 Aug; 6(8):1325-37. PubMed ID: 20799877
[TBL] [Abstract][Full Text] [Related]
47. [Scintigraphic diagnosis of inflammation and infection].
Todorović-Tirnanić M; Obradović V; Artiko V; Sobic-Saranović D; Davidović B; Pavlović S; Bosnjaković V
Glas Srp Akad Nauka Med; 2005; (48):55-83. PubMed ID: 16405231
[TBL] [Abstract][Full Text] [Related]
48. Nuclear medicine in the detection, staging and treatment of gastrointestinal carcinoid tumours.
Oberg K; Eriksson B
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):265-76. PubMed ID: 15763700
[TBL] [Abstract][Full Text] [Related]
49. The Influence of Different Spacers on Biological Profile of Peptide Radiopharmaceuticals for Diagnosis and Therapy of Human Cancers.
Farahani AM; Maleki F; Sadeghzadeh N
Anticancer Agents Med Chem; 2020; 20(4):402-416. PubMed ID: 31889492
[TBL] [Abstract][Full Text] [Related]
50. Receptor-mediated tumor targeting with radiopeptides. Part 1. General principles and methods.
Eberle AN; Mild G
J Recept Signal Transduct Res; 2009; 29(1):1-37. PubMed ID: 19519167
[TBL] [Abstract][Full Text] [Related]
51. Radiolabeled regulatory peptides for imaging and therapy.
Nanda PK; Lane SR; Retzloff LB; Pandey US; Smith CJ
Curr Opin Endocrinol Diabetes Obes; 2010 Feb; 17(1):69-76. PubMed ID: 19901831
[TBL] [Abstract][Full Text] [Related]
52. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract][Full Text] [Related]
53. Recent developments in 99Tcm-labelled peptide-based radiopharmaceuticals: an overview.
Okarvi SM
Nucl Med Commun; 1999 Dec; 20(12):1093-112. PubMed ID: 10664991
[TBL] [Abstract][Full Text] [Related]
54. Application of radiolabeled peptides in tumor imaging and therapy.
Mohtavinejad N; Shafiee Ardestani M; Khalaj A; Pormohammad A; Najafi R; Bitarafan-Rajabi A; Hajiramezanali M; Amanlou M
Life Sci; 2020 Oct; 258():118206. PubMed ID: 32758623
[TBL] [Abstract][Full Text] [Related]
55. [Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting.
Wild D; Béhé M; Wicki A; Storch D; Waser B; Gotthardt M; Keil B; Christofori G; Reubi JC; Mäcke HR
J Nucl Med; 2006 Dec; 47(12):2025-33. PubMed ID: 17138746
[TBL] [Abstract][Full Text] [Related]
56. Radiopharmaceuticals for the visualization of infectious and inflammatory lesions.
Ercan MT; Kostakoğlu L
Curr Pharm Des; 2000 Jul; 6(11):1159-77. PubMed ID: 10903388
[TBL] [Abstract][Full Text] [Related]
57. Radiolabeling of bombesin-like peptide with 99mTc: 99mTc-litorin and biodistribution in rats.
Durkan K; Lambrecht FY; Unak P
Bioconjug Chem; 2007; 18(5):1516-20. PubMed ID: 17760415
[TBL] [Abstract][Full Text] [Related]
58. Regulatory peptide receptors as molecular targets for cancer diagnosis and therapy.
Reubi JC
Q J Nucl Med; 1997 Jun; 41(2):63-70. PubMed ID: 9203845
[TBL] [Abstract][Full Text] [Related]
59. Radiolabelled antimicrobial peptides for infection detection.
Lupetti A; Welling MM; Pauwels EK; Nibbering PH
Lancet Infect Dis; 2003 Apr; 3(4):223-9. PubMed ID: 12679265
[TBL] [Abstract][Full Text] [Related]
60. Nuclear medicine in the detection and management of pancreatic islet-cell tumours.
Virgolini I; Traub-Weidinger T; Decristoforo C
Best Pract Res Clin Endocrinol Metab; 2005 Jun; 19(2):213-27. PubMed ID: 15763696
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
